Učitavanje...
Evaluating biomarkers for prognostic enrichment of clinical trials
BACKGROUND/AIMS: A potential use of biomarkers is to assist in prognostic enrichment of clinical trials, where only patients at relatively higher risk for an outcome of interest are eligible for the trial. We investigated methods for evaluating biomarkers for prognostic enrichment. METHODS: We ident...
Spremljeno u:
| Izdano u: | Clin Trials |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5714681/ https://ncbi.nlm.nih.gov/pubmed/28795578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774517723588 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|